Simon Kohl, CEO and Founder of Latent Labs, appeared on Bloomberg News Daybreak Europe this morning to discuss our $50M Series A funding round and our approach to making biology programmable. As Simon articulated, "We're building frontier AI models that learn the fundamentals of biochemistry, and we will be able to apply these successfully to antibody design, protein engineering, such as enzyme optimization, built tooling for genetic engineering, and we do believe that there is a significant opportunity to move the drug discovery process into the computational realm. That is our North Star." You can watch the full interview starting from 37:05 at the link below: https://lnkd.in/eEQDNU_z Thank you to the team at Bloomberg Daybreak Europe and Tom Mackenzie for the conversation.
This morning, I had the privilege of discussing Latent Labs' recent $50M funding and our mission to make biology programmable on Bloomberg News Daybreak Europe. Our goal at Latent Labs is to build frontier AI models that learn the fundamentals of biochemistry. Thank you to Tom Mackenzie and the Bloomberg Daybreak team for the conversation. For those interested, you can watch the full interview starting at 37:05 via the link below: https://lnkd.in/edCauK_q
